Difference between revisions of "Talk:Main Page"
(I'm retired <a href=" http://theacceleratornetwork.com/l-arginine-for-premature-ejaculation.pdf#gamble ">l-arginine side effects skin</a> Serco Group faces a six-week deadline to improve itsperforman) |
(Another year <a href=" http://idealcases.co.uk/cheap-tadasoft.pdf#archipelago ">cheap tadasoft</a> Professor Chris Mason, a stem cell biologist at University College London, said the big challenge fo) |
||
| Line 1: | Line 1: | ||
| − | + | Another year <a href=" http://idealcases.co.uk/cheap-tadasoft.pdf#archipelago ">cheap tadasoft</a> Professor Chris Mason, a stem cell biologist at University College London, said the big challenge for Prof Ali's work would be whether it worked in patients. "Restoring the sight for the 'three blind mice' may be far easier than for the 'farmer's wife'. Before human clinical trials can commence, the mouse model will require significant optimisation, for example increasing the efficiency of new photoreceptors to connect with the damaged retina. However, there is no doubt that this breakthrough, either directly as the basis of a future cell therapy, or indirectly by expanding our knowledge, will significantly contribute to the fight against blindness." | |
Revision as of 06:10, 15 August 2015
Another year <a href=" http://idealcases.co.uk/cheap-tadasoft.pdf#archipelago ">cheap tadasoft</a> Professor Chris Mason, a stem cell biologist at University College London, said the big challenge for Prof Ali's work would be whether it worked in patients. "Restoring the sight for the 'three blind mice' may be far easier than for the 'farmer's wife'. Before human clinical trials can commence, the mouse model will require significant optimisation, for example increasing the efficiency of new photoreceptors to connect with the damaged retina. However, there is no doubt that this breakthrough, either directly as the basis of a future cell therapy, or indirectly by expanding our knowledge, will significantly contribute to the fight against blindness."
